glp 1 inhibitors GLP-1 Agonists - What is it? Evolution of GLP‐1 Receptor Agonists

FRIDAY, Aug

Discover how microdosing GLP-1s can have low side effects, low costs, and support weight loss

By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy

In the search for novel treatment strategies for alcohol use disorder (AUD), glucagonlike peptide1 (GLP1) receptor agonists (GLP1RAs) approved for treating Type 2 diabetes and obesity have caught much attention

As the number of diabetic patien...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 diabetes patients.